These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16690350)

  • 41. Comparison of the performance of paired urine and cervical samples for cervical cancer screening in screening population.
    Xu H; Yu Y; George W; Smith JS; Hu S; Dang L; Zhang X; Pan Q; Qiao Y; Zhao F
    J Med Virol; 2020 Feb; 92(2):234-240. PubMed ID: 31535725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus deoxyribonucleic acid detection in mildly or moderately dysplastic smears: a possible method for selecting patients for colposcopy.
    Bollen LJ; Tjong-A-Hung SP; van der Velden J; Brouwer K; Mol BW; ten Kate FJ; ter Schegget J
    Am J Obstet Gynecol; 1997 Sep; 177(3):548-53. PubMed ID: 9322622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
    Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
    J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of human papillomavirus (HPV) genotypes in cervico-vaginal scrapes of women with normal and abnormal cytology.
    Finan RR; Irani-Hakime N; Tamim H; Sharide HE; Daccache JL; Almawi WY
    Clin Microbiol Infect; 2001 Dec; 7(12):688-92. PubMed ID: 11843911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer.
    Moberg M; Gustavsson I; Gyllensten U
    J Clin Microbiol; 2003 Jul; 41(7):3221-8. PubMed ID: 12843067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
    Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
    J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
    Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
    Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.
    Carozzi F; Cecchini S; Confortini M; Becattini V; Cariaggi MP; Pontenani G; Sani C; Ciatto S
    Cancer; 2006 Apr; 108(2):119-23. PubMed ID: 16411180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.
    Fontaine J; Hankins C; Mayrand MH; Lefevre J; Money D; Gagnon S; Rachlis A; Pourreaux K; Ferenczy A; Coutlée F;
    AIDS; 2005 May; 19(8):785-94. PubMed ID: 15867492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs.
    Palmisano ME; Gaffga AM; Daigle J; Brinkman J; Mire K; Lenczyk K; Martin DH; Hagensee ME
    Int J STD AIDS; 2003 Aug; 14(8):560-7. PubMed ID: 12935387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.
    Swan DC; Tucker RA; Tortolero-Luna G; Mitchell MF; Wideroff L; Unger ER; Nisenbaum RA; Reeves WC; Icenogle JP
    J Clin Microbiol; 1999 Apr; 37(4):1030-4. PubMed ID: 10074522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
    Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
    BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous evolution of human papillomavirus infection in the uterine cervix.
    Paraskevaidis E; Kalantaridou SN; Georgiou I; Koliopoulos G; Pappa L; Malamou-Mitsi V; Agnantis NJ; Kitchener HC; Lolis DE
    Anticancer Res; 1999; 19(4C):3473-8. PubMed ID: 10629638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
    Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
    JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
    Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.